216 related articles for article (PubMed ID: 30767057)
1. Congenital myasthenic syndrome caused by novel COL13A1 mutations.
Dusl M; Moreno T; Munell F; Macaya A; Gratacòs M; Abicht A; Strom TM; Lochmüller H; Senderek J
J Neurol; 2019 May; 266(5):1107-1112. PubMed ID: 30767057
[TBL] [Abstract][Full Text] [Related]
2. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations.
Rodríguez Cruz PM; Cossins J; Estephan EP; Munell F; Selby K; Hirano M; Maroofin R; Mehrjardi MYV; Chow G; Carr A; Manzur A; Robb S; Munot P; Wei Liu W; Banka S; Fraser H; De Goede C; Zanoteli E; Conti Reed U; Sage A; Gratacos M; Macaya A; Dusl M; Senderek J; Töpf A; Hofer M; Knight R; Ramdas S; Jayawant S; Lochmüller H; Palace J; Beeson D
Brain; 2019 Jun; 142(6):1547-1560. PubMed ID: 31081514
[TBL] [Abstract][Full Text] [Related]
3. Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain.
Logan CV; Cossins J; Rodríguez Cruz PM; Parry DA; Maxwell S; Martínez-Martínez P; Riepsaame J; Abdelhamed ZA; Lake AV; Moran M; Robb S; Chow G; Sewry C; Hopkins PM; Sheridan E; Jayawant S; Palace J; Johnson CA; Beeson D
Am J Hum Genet; 2015 Dec; 97(6):878-85. PubMed ID: 26626625
[TBL] [Abstract][Full Text] [Related]
4. Congenital myasthenic syndrome type 19 due to a novel mutation in the COL13A1 GENE.
Marquardt RJ; Li Y
Muscle Nerve; 2019 Jul; 60(1):E3-E4. PubMed ID: 31018245
[No Abstract] [Full Text] [Related]
5. Myasthenic syndromes due to defects in COL13A1 and in the N-linked glycosylation pathway.
Beeson D; Cossins J; Rodriguez Cruz PM; Maxwell S; Liu WW; Palace J
Ann N Y Acad Sci; 2018 Feb; 1413(1):163-169. PubMed ID: 29363764
[TBL] [Abstract][Full Text] [Related]
6. A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin.
Abicht A; Stucka R; Karcagi V; Herczegfalvi A; Horváth R; Mortier W; Schara U; Ramaekers V; Jost W; Brunner J; Janssen G; Seidel U; Schlotter B; Müller-Felber W; Pongratz D; Rüdel R; Lochmüller H
Neurology; 1999 Oct; 53(7):1564-9. PubMed ID: 10534268
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
[TBL] [Abstract][Full Text] [Related]
9. The CMS19 disease model specifies a pivotal role for collagen XIII in bone homeostasis.
Kemppainen AV; Finnilä MA; Heikkinen A; Härönen H; Izzi V; Kauppinen S; Saarakkala S; Pihlajaniemi T; Koivunen J
Sci Rep; 2022 Apr; 12(1):5866. PubMed ID: 35393492
[TBL] [Abstract][Full Text] [Related]
10. Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.
Guergueltcheva V; Müller JS; Dusl M; Senderek J; Oldfors A; Lindbergh C; Maxwell S; Colomer J; Mallebrera CJ; Nascimento A; Vilchez JJ; Muelas N; Kirschner J; Nafissi S; Kariminejad A; Nilipour Y; Bozorgmehr B; Najmabadi H; Rodolico C; Sieb JP; Schlotter B; Schoser B; Herrmann R; Voit T; Steinlein OK; Najafi A; Urtizberea A; Soler DM; Muntoni F; Hanna MG; Chaouch A; Straub V; Bushby K; Palace J; Beeson D; Abicht A; Lochmüller H
J Neurol; 2012 May; 259(5):838-50. PubMed ID: 21975507
[TBL] [Abstract][Full Text] [Related]
11. Moderate phenotype of a congenital myasthenic syndrome type 19 caused by mutation of the COL13A1 gene: a case report.
Kediha MI; Tazir M; Sternberg D; Eymard B; Alipacha L
J Med Case Rep; 2022 Mar; 16(1):134. PubMed ID: 35337379
[TBL] [Abstract][Full Text] [Related]
12. Collagen XIII Is Required for Neuromuscular Synapse Regeneration and Functional Recovery after Peripheral Nerve Injury.
Zainul Z; Heikkinen A; Koivisto H; Rautalahti I; Kallio M; Lin S; Härönen H; Norman O; Rüegg MA; Tanila H; Pihlajaniemi T
J Neurosci; 2018 Apr; 38(17):4243-4258. PubMed ID: 29626165
[TBL] [Abstract][Full Text] [Related]
13. Novel COLQ mutation 950delC in synaptic congenital myasthenic syndrome and symptomatic heterozygous relatives.
Schreiner F; Hoppenz M; Klaeren R; Reimann J; Woelfle J
Neuromuscul Disord; 2007 Mar; 17(3):262-5. PubMed ID: 17300939
[TBL] [Abstract][Full Text] [Related]
14. Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.
Belaya K; Rodríguez Cruz PM; Liu WW; Maxwell S; McGowan S; Farrugia ME; Petty R; Walls TJ; Sedghi M; Basiri K; Yue WW; Sarkozy A; Bertoli M; Pitt M; Kennett R; Schaefer A; Bushby K; Parton M; Lochmüller H; Palace J; Muntoni F; Beeson D
Brain; 2015 Sep; 138(Pt 9):2493-504. PubMed ID: 26133662
[TBL] [Abstract][Full Text] [Related]
15. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.
Rodríguez Cruz PM; Palace J; Beeson D
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874875
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic heterogeneity in two large Roma families with a congenital myasthenic syndrome due to CHRNE 1267delG mutation. A long-term follow-up.
Natera-de Benito D; Domínguez-Carral J; Muelas N; Nascimento A; Ortez C; Jaijo T; Arteaga R; Colomer J; Vilchez JJ
Neuromuscul Disord; 2016 Nov; 26(11):789-795. PubMed ID: 27634344
[TBL] [Abstract][Full Text] [Related]
17. Recessive VAMP1 mutations associated with severe congenital myasthenic syndromes - A recognizable clinical phenotype.
Polavarapu K; Vengalil S; Preethish-Kumar V; Arunachal G; Nashi S; Mohan D; Chawla T; Bardhan M; Nandeesh B; Gupta P; Gowda VK; Lochmüller H; Nalini A
Eur J Paediatr Neurol; 2021 Mar; 31():54-60. PubMed ID: 33631708
[TBL] [Abstract][Full Text] [Related]
18. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.
Müller JS; Mildner G; Müller-Felber W; Schara U; Krampfl K; Petersen B; Petrova S; Stucka R; Mortier W; Bufler J; Kurlemann G; Huebner A; Merlini L; Lochmüller H; Abicht A
Neurology; 2003 Jun; 60(11):1805-10. PubMed ID: 12796535
[TBL] [Abstract][Full Text] [Related]
19. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
Tsao CY
Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
[TBL] [Abstract][Full Text] [Related]
20. Correct expression and localization of collagen XIII are crucial for the normal formation and function of the neuromuscular system.
Härönen H; Zainul Z; Naumenko N; Sormunen R; Miinalainen I; Shakirzyanova A; Santoleri S; Kemppainen AV; Giniatullin R; Pihlajaniemi T; Heikkinen A
Eur J Neurosci; 2019 Jun; 49(11):1491-1511. PubMed ID: 30667565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
